Search Results - "Skaer, T L"

Refine Results
  1. 1

    The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women by Fournier, L R, Ryan Borchers, T A, Robison, L M, Wiediger, M, Park, J S, Chew, B P, McGuire, M K, Sclar, D A, Skaer, T L, Beerman, K A

    Published in The Journal of nutrition, health & aging (01-03-2007)
    “…The decline in estrogen concentrations in women after menopause can contribute to health related changes including impairments in cognition, especially memory…”
    Get more information
    Journal Article
  2. 2

    National Trends in the Prevalence of Attention-Deficit/Hyperactivity Disorder and the Prescribing of Methylphenidate among School-Age Children: 1990-1995 by Robison, Linda M., Sclar, David A., Skaer, Tracy L., Galin, Richard S.

    Published in Clinical pediatrics (01-04-1999)
    “…It has been reported that during the past decade the prevalence of attention-deficit/ hyperactivity disorder (ADHD) (ICD-9-CM code 314.00 or 314.01) and its…”
    Get full text
    Journal Article
  3. 3

    Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization by Sclar, D A, Robison, L M, Skaer, T L, Legg, R F, Nemec, N L, Galin, R S, Hughes, T E, Buesching, D P

    Published in Clinical therapeutics (01-07-1994)
    “…Recent pharmacotherapeutic advances in the treatment of depression have included the development of selective serotonin re-uptake inhibitors (SSRIs). The…”
    Get more information
    Journal Article
  4. 4

    Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organization by Sclar, D A, Robison, L M, Skaer, T L, Galin, R S, Legg, R F, Nemec, N L, Hughes, T E, Buesching, D P, Morgan, M

    Published in Journal of international medical research (01-11-1995)
    “…The present study was designed to compare direct health service expenditures, for the treatment of depression, among patients enrolled in a health maintenance…”
    Get more information
    Journal Article
  5. 5

    Medication-induced systemic lupus erythematosus by Skaer, T L

    Published in Clinical therapeutics (01-07-1992)
    “…Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease affecting a variety of tissues and organs. The diagnosis of SLE can be made only after…”
    Get more information
    Journal Article
  6. 6

    Trends in the prescribing of antidepressant pharmacotherapy: office-based visits, 1990–1995 by Sclar, David A., Robison, Linda M., Skaer, Tracy L., Galin, Richard S.

    Published in Clinical therapeutics (01-07-1998)
    “…Data from the National Ambulatory Medical Care Survey for the period 1990 through 1995 were used to discern the population-adjusted rate of office-based…”
    Get full text
    Journal Article
  7. 7

    Clinical presentation and treatment of migraine by Skaer, Tracy L.

    Published in Clinical therapeutics (01-03-1996)
    “…The pathogenesis of migraine is not completely understood but may involve vasodilation of cerebral blood vessels and/or the release of vasoactive neuropeptides…”
    Get full text
    Journal Article
  8. 8

    Management of pain in the cancer patient by Skaer, T L

    Published in Clinical therapeutics (01-07-1993)
    “…Pain is the most common symptom experienced in patients with advanced cancer. This pain may be acute, chronic, or intermittent, and often has a definable…”
    Get more information
    Journal Article
  9. 9

    Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures--a study of patients with non-insulin-dependent diabetes mellitus by Skaer, T L, Sclar, D A, Markowski, D J, Won, J K

    “…An estimated 20 million Americans suffer from diabetes. Patients with non-insulin-dependent diabetes mellitus (NIDDM) comprise approximately 90% of the…”
    Get more information
    Journal Article
  10. 10

    Trend in the use of antidepressant pharmacotherapy and diagnosis of depression in the US: An assessment of office-based visits 1990 to 1998 by SKAER, Tracy L, SCLAR, David A, ROBISON, Linda M, GALIN, Richard S

    Published in CNS drugs (01-12-2000)
    “…Objective: To discern population-adjusted rates of office- based physician visits in the US documenting the use of antidepressant pharmacotherapy, a diagnosis…”
    Get full text
    Journal Article
  11. 11

    Effect of value-added utilities on prescription refill compliance and health care expenditures for hypertension by Skaer, T L, Sclar, D A, Markowski, D J, Won, J K

    Published in Journal of human hypertension (01-10-1993)
    “…A randomised trial was undertaken to discern the effect of pharmacy-based value-added utilities on prescription refill compliance with antihypertensive therapy…”
    Get more information
    Journal Article
  12. 12

    Dosing considerations in the pediatric patient by Skaer, T L

    Published in Clinical therapeutics (01-09-1991)
    “…Pediatric patients experience unique differences from the adult population in pharmacokinetic parameters and, consequently, require individualized dosing…”
    Get more information
    Journal Article
  13. 13

    Total parenteral nutrition: clinical considerations by Skaer, T L

    Published in Clinical therapeutics (01-03-1993)
    “…Nutritional support is recognized as an important therapeutic intervention to promote wound healing sustained traumatically, surgically, or caused by…”
    Get more information
    Journal Article
  14. 14

    Effect of health education in promoting prescription refill compliance among patients with hypertension by Sclar, D A, Chin, A, Skaer, T L, Okamoto, M P, Nakahiro, R K, Gill, M A

    Published in Clinical therapeutics (01-07-1991)
    “…A multifactorial health-education program designed to enhance compliance with a once-daily regimen of atenolol was evaluated among 453 patients enrolled in…”
    Get more information
    Journal Article
  15. 15

    What factors influence the prescribing of antidepressant pharmacotherapy? An assessment of national office-based encounters by Sclar, D A, Robison, L M, Skaer, T L, Galin, R S

    “…This study was designed to identify: 1) predictors of antidepressant pharmacotherapy among patients diagnosed with depression; and 2) predictors of…”
    Get more information
    Journal Article
  16. 16

    The need for an iterative process for assessing economic outcomes associated with SSRIs by Skaer, T L, Sclar, D A, Robison, L M, Galin, R S

    Published in PharmacoEconomics (01-09-2000)
    “…Pharmacotherapeutic advances in the treatment of depression have included the development of the selective serotonin reuptake inhibitors (SSRIs), thereby…”
    Get full text
    Journal Article
  17. 17

    Ipratropium bromide in the management of chronic obstructive pulmonary disease: effect on health service expenditures by Sclar, D A, Legg, R F, Skaer, T L, Robison, L M, Nemic, N L

    Published in Clinical therapeutics (01-05-1994)
    “…Chronic obstructive pulmonary disease (COPD), which is estimated to affect 32 million Americans, is the fifth leading cause of death in the United States. This…”
    Get more information
    Journal Article
  18. 18

    Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants by ROBISON, Linda M, SKAER, Tracy L, SCLAR, David A, GALIN, Richard S

    Published in CNS drugs (2002)
    “…To use a single national data source to discern trends in the prevalence of office-based visits resulting in a diagnosis of attention deficit hyperactivity…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Effect of pharmaceutical formulation for antihypertensive therapy on health service utilization by Skaer, T L, Sclar, D A, Robison, L M, Chin, A, Gill, M A, Okamoto, M P, Nakahiro, R K

    Published in Clinical therapeutics (01-07-1993)
    “…A significant factor in the management of hypertension is the extent to which patients comply with the treatment regimen. A retrospective analysis was…”
    Get more information
    Journal Article